investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Regulation of Leukemia Stem Cell Activity by Signaling through PKC[theta]
Andrew Weng
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Andrew Weng
BC Cancer Agency
Vancouver, Canada
Related projects
Terry Fry
Adoptive T cell Therapy for Pediatric Leukemia
Leukaemia
Pediatric oncology or childhood cancer
Peter Aplan
Collaborative Pathways that Lead to Leukemia – Rockville
Leukaemia
Pathology
Hematology and hematologic malignancies
Aaron David Schimmer
Inhibiting oncogenic kinases to target metabolism in AML
Leukaemia
Hanyang Lin
Identification of new microRNA biomarkers and candidate target genes in primitive CML cells using global comparative RNA analyses
Leukaemia
Xiaoyan Jiang
Molecular Targeting of Critical Domains of AHI-1 Oncoprotein in Chronic Myeloid Leukemia Stem Cells Resistant to Current Tyrosine Kinase Inhibitor Therapy
Leukaemia
Scott H Kaufmann
Regulation of Death Ligand-Induced Killing
Leukaemia
Pathology
Hematology and hematologic malignancies
Tak Mak
CRC Tier 1 - Determining why mutations of the metabolic enzyme isocitrate dehydrogenase cause leukemias and brain cancers
Leukaemia
Monica J Justice
The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms
Leukaemia
Pathology
Hematology and hematologic malignancies
Tomasz Skorski
BCR/ABL-PI-3k-ROS pathway induce genomic instability ....
Leukaemia
Pathology
Hematology and hematologic malignancies